Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Aishatu Mohammed Nalado, Johnny N Mahlangu, Bala Waziri, Raquel Duarte, Graham Paget, Gbenga Olorunfemi & Saraladevi Naicker. (2019) Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa. International Journal of Nephrology and Renovascular Disease 12, pages 19-32.
Read now
Read now
Hong-Jin Zhao, Yan Li, Shan-Mei Liu, Xiang-Guo Sun, Min Li, Yan Hao, Lian-Qun Cui & Ai-Hong Wang. (2016) Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis. Renal Failure 38:6, pages 849-856.
Read now
Read now
Rafia S. Rasu, Tonya Crawford, Harold Manley & Rajesh Balkrishnan. (2008) Treatment and costs associated with anemic chronic kidney disease patients. Current Medical Research and Opinion 24:1, pages 129-137.
Read now
Read now
Huifang Cheng & Raymond C Harris. (2006) Potential side effects of renin inhibitors – mechanisms based on comparison with other renin–angiotensin blockers. Expert Opinion on Drug Safety 5:5, pages 631-641.
Read now
Read now
J. D. Jensen, H. Eiskjær, B. Madsen, M. Egeblad, C. B. Nielsen & E. B. Pedersen. (1993) Effect of captopril on the renal veno-arterial gradient of erythropoietin and oxygen in unilateral renal artery disease. Scandinavian Journal of Clinical and Laboratory Investigation 53:8, pages 859-865.
Read now
Read now
Articles from other publishers (68)
Tess E Cooper, Claris Teng, David J Tunnicliffe, Brydee A Cashmore & Giovanni FM Strippoli. (2023) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease. Cochrane Database of Systematic Reviews 2023:7.
Crossref
Crossref
Taiki Hori, Shingen Nakamura, Hiroki Yamagami, Saya Yasui, Minae Hosoki, Tomoyo Hara, Yukari Mitsui, Shiho Masuda, Kiyoe Kurahashi, Sumiko Yoshida, Takeshi Harada, Akio Kuroda, Toshiki Otoda, Tomoyuki Yuasa, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe & Ken-ichi Aihara. (2023) Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes. Heliyon 9:4, pages e14724.
Crossref
Crossref
K. I. Papadopoulos, A. Papadopoulou & T. C. Aw. (2023) Beauty and the beast: host microRNA-155 versus SARS-CoV-2. Human Cell 36:3, pages 908-922.
Crossref
Crossref
Yukiko Yasuoka, Yuichiro Izumi, Takashi Fukuyama, Hideki Inoue, Tomomi Oshima, Taiga Yamazaki, Takayuki Uematsu, Noritada Kobayashi, Yoshitaka Shimada, Yasushi Nagaba, Masashi Mukoyama, Yuichi Sato, Jeff M Sands, Katsumasa Kawahara & Hiroshi Nonoguchi. (2021) Effects of Angiotensin II on Erythropoietin Production in the Kidney and Liver. Molecules 26:17, pages 5399.
Crossref
Crossref
George Pavlidis, Sotirios G. Papageorgiou, Efthimia Bazani, Anthi Bouchla, Eirini Glezou, Konstantinos Gkontopoulos, Thomas Thomopoulos, Vasiliki Pappa & Demetrios V. Vlahakos. (2021) Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes. Therapeutic Advances in Hematology 12, pages 204062072095829.
Crossref
Crossref
Demetrios V. Vlahakos, Costas Tsioufis, Athanasios Manolis, Gerasimos Filippatos, Katerina P. Marathias, Vasilios Papademetriou & Giuseppe Mancia. (2019) Inhibition of the renin-angiotensin system in the cardiorenal syndrome with anaemia. Journal of Hypertension 37:11, pages 2145-2153.
Crossref
Crossref
Nicolas Roberto Robles, Juan Lucio Ramos, Edgar Chavez, Boris Gonzalez Candia, Miguel Angel Bayo, Antonio Cidoncha, Juan Lopez Gomez & Juan Jose Cubero. (2018) Iron deficiency in chronic kidney disease patients with diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12:6, pages 933-937.
Crossref
Crossref
Yukiko Yasuoka, Yuichiro Izumi, Takanori Nagai, Takashi Fukuyama, Yushi Nakayama, Hideki Inoue, Kahori Horikawa, Miho Kimura, Masayoshi Nanami, Kengo Yanagita, Tomomi Oshima, Taiga Yamazaki, Takayuki Uematsu, Rui Yamamura, Noritada Kobayashi, Yoshitaka Shimada, Yasushi Nagaba, Takeshi Nakanishi, Tetsuro Yamashita, Masashi Mukoyama, Yuichi Sato, Katsumasa Kawahara & Hiroshi Nonoguchi. (2018) Fludrocortisone stimulates erythropoietin production in the intercalated cells of the collecting ducts. Biochemical and Biophysical Research Communications 503:4, pages 3121-3127.
Crossref
Crossref
W. Cheungpasitporn, C. Thongprayoon, T. Chiasakul, S. Korpaisarn & S.B. Erickson. (2015) Renin-angiotensin system inhibitors linked to anemia: a systematic review and meta-analysis. QJM 108:11, pages 879-884.
Crossref
Crossref
Morten Schou, Helle Bosselmann, Freja Gaborit, Kasper Iversen, Jens P. Goetze, Georg Soletomas, Jon Rasmussen, Caroline Kistorp, Lars Kober, Finn Gustafsson & Niels Tonder. (2015) Iron deficiency: Prevalence and relation to cardiovascular biomarkers in heart failure outpatients. International Journal of Cardiology 195, pages 143-148.
Crossref
Crossref
William G. Murphy. (2014) The sex difference in haemoglobin levels in adults — Mechanisms, causes, and consequences. Blood Reviews 28:2, pages 41-47.
Crossref
Crossref
Adnan Ajmal, Charles E Gessert, Brian P Johnson, Colleen M Renier & Jeanette A Palcher. (2013) Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels. BMC Research Notes 6:1.
Crossref
Crossref
Alice Laudisio, Emanuele Marzetti, Francesco Pagano & Roberto Bernabei. (2013) Introduction of angiotensin-converting enzyme inhibitors induces a fall in hemoglobin levels in elderly patients hospitalized with heart failure: a cohort study. Aging Clinical and Experimental Research 24:2, pages 145-151.
Crossref
Crossref
Pawana Sharma, Rachel C Blackburn, Claire L Parke, Keith McCullough, Angharad Marks & Corri Black. (2011) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
E. Lars Penne, Neelke C. van der Weerd, Muriel P.C. Grooteman, Albert H.A. Mazairac, Marinus A. van den Dorpel, Menso J. Nubé, Michiel L. Bots, Renée Lévesque, Piet M. ter Wee & Peter J. Blankestijn. (2011) Role of Residual Renal Function in Phosphate Control and Anemia Management in Chronic Hemodialysis Patients. Clinical Journal of the American Society of Nephrology 6:2, pages 281-289.
Crossref
Crossref
M. C. J. Slagman, S. J. Sinkeler, M. H. Hemmelder, F. Waanders, L. Vogt, H. C. Kluin-Nelemans, G. Navis & G. D. Laverman. (2010) Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function. Nephrology Dialysis Transplantation 25:10, pages 3256-3260.
Crossref
Crossref
Demetrios V. Vlahakos, Katerina P. Marathias & Nicolaos E. Madias. (2010) The Role of the Renin-Angiotensin System in the Regulation of Erythropoiesis. American Journal of Kidney Diseases 56:3, pages 558-565.
Crossref
Crossref
Olivier Moranne, Marc Froissart, Jerome Rossert, Cedric Gauci, Jean-Jacques Boffa, Jean Philippe Haymann, Mona Ben M’rad, Christian Jacquot, Pascal Houillier, Benedicte Stengel & Bruno Fouqueray. (2009) Timing of Onset of CKD-Related Metabolic Complications. Journal of the American Society of Nephrology 20:1, pages 164-171.
Crossref
Crossref
A. Inoue, T. Babazono & Y. Iwamoto. (2008) Effects of the Renin-Angiotensin System Blockade on Hemoglobin Levels in Type 2 Diabetic Patients With Chronic Kidney Disease. American Journal of Hypertension 21:3, pages 317-322.
Crossref
Crossref
Shozo Yano, Keiko Suzuki, Masataka Iwamoto, Yoshinori Urushidani, Hiroyuki Yokogi, Masuo Kusakari, Akihiko Aoki, Masaaki Sumi, Kenjiro Kitamura, Hiromi Sanematsu, Masaru Gohbara, Sadao Imamura & Toshitsugu Sugimoto. (2008) Association between Erythropoietin Requirements and Antihypertensive Agents. Nephron Clinical Practice 109:1, pages c33-c39.
Crossref
Crossref
J.I. Artero Muñoz, A.B. Marín Floria, C. Cerdán Lanero & Á. Aznar Carbonell. (2007) Anemia por fosinopril. SEMERGEN - Medicina de Familia 33:6, pages 337.
Crossref
Crossref
R. Ravanan, J. R. Spiro, P. W. Mathieson & R. M. Smith. (2006) Impact of diabetes on haemoglobin levels in renal disease. Diabetologia 50:1, pages 26-31.
Crossref
Crossref
Vittorino Ripamonti, Vittorio Racca, Maria G. Calvo, Paolo Castiglioni & Maurizio Ferratini. (2006) Angiotensin-Converting Enzyme Inhibitors Slow Recovery From Anemia Following Cardiac Surgery. Chest 130:1, pages 79-84.
Crossref
Crossref
Anumeet Priyadarshi & Joseph I. Shapiro. (2006) HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Erythropoietin Resistance in the Treatment of the Anemia of Chronic Renal Failure. Seminars in Dialysis 19:4, pages 273-278.
Crossref
Crossref
Kenneth E. BernsteinHong D. XiaoKristen FrenzelPing LiXiao Z. ShenJon W. AdamsSebastien Fuchs. (2005)
Six
Truisms
Concerning ACE and the Renin-Angiotensin System Educed From the Genetic Analysis of Mice
. Circulation Research 96:11, pages 1135-1144.
Crossref
Crossref
Steven Gabardi & Stuart Abramson. (2005) Drug Dosing in Chronic Kidney Disease. Medical Clinics of North America 89:3, pages 649-687.
Crossref
Crossref
Tarek M. El-Achkar, Suzanne E. Ohmit, Peter A. Mccullough, Errol D. Crook, Wendy W. Brown, Richard Grimm, George L. Bakris, William F. Keane & John M. Flack. (2005) Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. Kidney International 67:4, pages 1483-1488.
Crossref
Crossref
Thomas Elung-Jensen, Jens Heisterberg, Jesper Sonne, Svend Strandgaard & Anne-Lise Kamper. (2005) Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial. European Journal of Clinical Pharmacology 61:2, pages 87-96.
Crossref
Crossref
H. P. Lefebvre & P. L. Toutain. (2004) Angiotensin-converting enzyme inhibitors in the therapy of renal diseases. Journal of Veterinary Pharmacology and Therapeutics 27:5, pages 265-281.
Crossref
Crossref
G. Michael Felker, Kirkwood F. AdamsJrJr, Wendy A. Gattis & Christopher M. O'Connor. (2004) Anemia as a risk factor and therapeutic target in heart failure. Journal of the American College of Cardiology 44:5, pages 959-966.
Crossref
Crossref
Klaus K.A Witte, Ramesh Desilva, Sudipta Chattopadhyay, Justin Ghosh, John G.F Cleland & Andrew L Clark. (2004) Are hematinic deficiencies the cause of anemia in chronic heart failure?. American Heart Journal 147:5, pages 924-930.
Crossref
Crossref
Demetrios V. Vlahakos, Katerina P. Marathias, Basil Agroyannis & Nicolaos E. Madias. (2003) Posttransplant erythrocytosis. Kidney International 63:4, pages 1187-1194.
Crossref
Crossref
Sandra Donnelly. 2003. Hypoxia. Hypoxia
73
87
.
Mark J Sarnak, Amin Al-Ahmad, William M Rand, Deeb Salem & Andrew S Levey. (2002) Reply. Journal of the American College of Cardiology 39:10, pages 1704-1705.
Crossref
Crossref
Angela Yee Moon Wang, Alex Wai Yin Yu, Christopher Wai Kei Lam, Ly Mee Yu, Philip Kam Tao Li, Juliana Goh & Siu Fai Lui. (2002) Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis. American Journal of Kidney Diseases 39:3, pages 600-608.
Crossref
Crossref
Allen R. Nissenson & Eric M. Tong. 2002. Improving Prognosis for Kidney Disorders. Improving Prognosis for Kidney Disorders
9
27
.
Sandra M Donnelly & Judith A Miller. (2016) Losartan may modulate erythropoietin production. Journal of the Renin-Angiotensin-Aldosterone System 2:4, pages 255-260.
Crossref
Crossref
Jan Gossmann, Ralf Burkhardt, Sebastian Harder, Tomas Lenz, Annette Sedlmeyer, Ute Klinkhardt, Helmut Geiger & Ernst-Heinrich Scheuermann. (2001) Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney International 60:1, pages 83-86.
Crossref
Crossref
Sofia Feinstein, Rachel Becker-Cohen, Nurti Algur, David Raveh, Hanna Shalev, Yigal Shvil & Yaacov Frishberg. (2001) Erythropoietin deficiency causes anemia in nephrotic children with normal kidney function. American Journal of Kidney Diseases 37:4, pages 736-742.
Crossref
Crossref
D Montanaro, M Gropuzzo, P Tulissi, G Boscutti, A Risaliti, U Baccarani & G Mioni. (2001) Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis. Transplantation Proceedings 33:1-2, pages 2038-2040.
Crossref
Crossref
Justin Cole, Dilek Ertoy, Hsinchen Lin, Roy L. Sutliff, Eric Ezan, Tham T. Guyene, Mario Capecchi, Pierre Corvol & Kenneth E. Bernstein. (2000) Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice. Journal of Clinical Investigation 106:11, pages 1391-1398.
Crossref
Crossref
Bidisha Chatterjee, Urs E. Nydegger & Paul Mohacsi. (2001)
Serum erythropoietin in heart failure patients treated with ACE‐inhibitors or AT
1
antagonists
. European Journal of Heart Failure 2:4, pages 393-398.
Crossref
Crossref
Ali K. Abu-Alfa, Dinna Cruz, Mark A. Perazella, Rex L. Mahnensmith, David Simon & Margaret J. Bia. (2000) Ace inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients. American Journal of Kidney Diseases 35:6, pages 1076-1082.
Crossref
Crossref
Şehsuvar Ertürk, Gökhan Nergizoğlu, Kenan Ateş, Neval Duman, Bülent Erbay, Oktay Karatan & A. Ergün Ertuğ. (1999) The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients. Nephrology Dialysis Transplantation 14:8, pages 1912-1916.
Crossref
Crossref
Iain C. Macdougall. (1999) The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin. Nephrology Dialysis Transplantation 14:8, pages 1836-1841.
Crossref
Crossref
R. Antonelli Incalzi, Antonella Gemma & PierUgo Carbonin. (1998) ACE INHIBITORS: A POSSIBLE CAUSE OF UNEXPLAINED ANEMIA. Journal of the American Geriatrics Society 46:1, pages 117-118.
Crossref
Crossref
J. Radermacher & Karl M. Koch. 1997. Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS
875
892
.
Mathew J. Lewis & Suzanne K. Swan. (2007) A Potpourri of Drug Idiosyncracies in ESRD. Seminars in Dialysis 10:5, pages 278-281.
Crossref
Crossref
Luigi F. Morrone, Salvatore Di Paolo, Francesco Logoluso, Antonio Schena, Giovanni Stallone, Francesco Giorgino & F. Paolo Schena. (1997) INTERFERENCE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ON ERYTHROPOIESIS IN KIDNEY TRANSPLANT RECIPIENTS. Transplantation 64:6, pages 913-918.
Crossref
Crossref
D. Ducloux & J.M. Chalopin. (1997) Losartan decreases hemoglobin in renal transplant recipients. Transplantation Proceedings 29:5, pages 2402-2403.
Crossref
Crossref
T. Yagisawa, H. Toma, H. Yaguchi, M. Tomaru, Y. Iijima, H. Suzuki & T. Nakada. (1997) Efficacy of Enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation. International Urology and Nephrology 29:3, pages 363-367.
Crossref
Crossref
Fernando Valderrábano. (1996) Erythropoietin in chronic renal failure. Kidney International 50:4, pages 1373-1391.
Crossref
Crossref
Dinna N. Cruz, Mark A. Perazella, Ali K. Abu-Alfa & Rex L. Mahnensmith. (1996) Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?. American Journal of Kidney Diseases 28:4, pages 535-540.
Crossref
Crossref
Jan Gossmann, Petra Thürmann, Thomas Bachmann, Stefan Weller, Hans-Georg Kachel, Wilhelm Schoeppe & Ernst-Heinrich Scheuermann. (1996) Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients. Kidney International 50:3, pages 973-978.
Crossref
Crossref
A. R. Nissenson. (2020) Hyporesponsiveness to Erythropoietin: Overview, 1996. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 16:4, pages 417-420.
Crossref
Crossref
Jesús Egido. (1996) Vasoactive hormones and renal sclerosis. Kidney International 49:2, pages 578-597.
Crossref
Crossref
K.C. Wong, K.S. Woo, W.K. Lam, K.T. Li, K.N. Lai, M.G. Nicholls & S.F. Lui. (2018) A Comparison of the Effect of Enalapril and Metoprolol on Renal Function, Potassium Balance, Lipid Profile, Cardiac Function, Exercise Tolerance and Quality of Life in Hypertensive Dialysis Patients. The International Journal of Artificial Organs 18:12, pages 757-762.
Crossref
Crossref
Mark Perazella, Peter McPhedran, Alan Kliger, Marc Lorber, Elliott Levy & Margaret J. Bia. (1995) Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels. American Journal of Kidney Diseases 26:3, pages 495-500.
Crossref
Crossref
Zbigniew Szyguła, Johan Smitz, Johan Roeykens, Kenny De Meirleir & Tom Klausen. (1995) An early effect of acute plasma volume expansion in humans on serum erythropoietin concentration. European Journal of Applied Physiology and Occupational Physiology 72:1-2, pages 106-110.
Crossref
Crossref
Bruce A. Julian, Robert S. Gaston, Catherine V. Barker, Gerald Krystal, Arnold G. Diethelm & John J. Curtis. (1994) Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis. Kidney International 46:5, pages 1397-1403.
Crossref
Crossref
L. D. Elving, J. F. M. Wetzels, H. J. J. van Lier, E. de Nobel & J. H. M. Berden. (1994) Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Diabetologia 37:6, pages 604-609.
Crossref
Crossref
R. Martino, A. Oliver, J. M. Ballarín & A. F. Remacha. (1994) Postrenal transplant erythrocytosis: Further evidence implicating erythropoietin production by the native kidneys. Annals of Hematology 68:4, pages 201-203.
Crossref
Crossref
Antonio Salvetti, Roberto Giovannetti, Pieranna Arrighi, Fabrizio Arzilli & Roberto Palla. (1993) What Effect Does Blood Pressure Control Have on the Progression Toward Renal Failure?. American Journal of Kidney Diseases 21:6, pages S10-S15.
Crossref
Crossref
J. D. JENSEN, H. EISKJÆR, J. P. BAGGER & E. B. PEDERSEN. (2009) Elevated level of erythropoietin in congestive heart failure Relationship to renal perfusion and plasma renin. Journal of Internal Medicine 233:2, pages 125-130.
Crossref
Crossref
MC Pratt, NJ Lewis‐Barned, RJ Walker, RR Bailey, BI Shand & J. Livesey. (2012) Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers.. British Journal of Clinical Pharmacology 34:4, pages 363-365.
Crossref
Crossref
Jeffrey W. Nielsen & Vincent J. Canzanello. (2007) Captopril and Anemia. Seminars in Dialysis 5:2, pages 159-160.
Crossref
Crossref
A. D. Graafland, C. J. Doorenbos & J. C. L. M. Saase. (1992) Enalapril-induced anemia in two kidney transplant recipients. Transplant International 5:1, pages 51-53.
Crossref
Crossref
S. Bjorck, H. Mulec, S. A. Johnsen, G. Norden & M. Aurell. (1992) Renal protective effect of enalapril in diabetic nephropathy.. BMJ 304:6823, pages 339-343.
Crossref
Crossref